Novel substituted 1,4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1231-1241

  Perchellet, Elisabeth M ^a   Wang, Yang ^a   Lou, Kaiyan ^a   Zhao, Huiping ^a   Battina, Srinivas K ^a   Hua, Duy H ^a   Perchellet, Jean Pierre H ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Antitumor 1,4 anthracenediones; Isolated mitochondria; Mitochondrial Ca2+ release; Mitochondrial swelling; Tumor cell proliferation

Indexed keywords

1,4 ANTHRAQUINONE; 1,4-ANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; CALCIUM; CARRIER PROTEIN; CYCLOSPORIN; CYTOCHROME C; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; DRUG EFFECT; HUMAN; LEUKEMIA L 1210; METABOLISM; MOUSE; SECRETION;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CALCIUM; CELL PROLIFERATION; CYCLOSPORINE; CYTOCHROMES C; HL-60 CELLS; HUMANS; LEUKEMIA L1210; MICE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS;

EID: 38449114259     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Perchellet EM, Magill MJ, Huang X, Dalke DM, Hua DH and Perchellet JP: 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro. Anticancer Drugs 11: 339-352, 2000.
2. Wu M, Wang B, Perchellet EM, Sperfslage BJ, Stephany HA, Hua DH and Perchellet JP: Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines. Anticancer Drugs 12: 807-819, 2001.
3. Perchellet EM, Wang Y, Weber RL, et al: Synthetic 1,4- anthracenedione analogs induce cytochrome c release, caspase- 9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Biochem Pharmacol 67: 523-537, 2004.
4. Hua DH, Lou K, Havens J, Perchellet EM, Wang Y, Perchellet JP and Iwamoto T: Synthesis and in vitro anti-tumor activity of substituted anthracene-1,4-diones. Tetrahedron 60: 10155-10163, 2004.
5. Hua DH, Lou K, Battina SK, Zhao H, Perchellet EM, Wang Y and Perchellet JP: Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs. Anticancer Agents Med Chem 6: 303-318, 2006.
6. Wang Y, Perchellet EM, Ward MM, Lou K, Hua DH and Perchellet JP: Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with antitumor 1,4-anthracenediones. Anticancer Drugs 16: 953-967, 2005.
7. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME and Debatin KM: Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 273: 33942-33948, 1998.
8. Susin SA, Larochette N, Geuskens M and Kroemer G: Purification of mitochondria for apoptosis assays. Methods Enzymol 322: 205-208, 2000.
9. Blattner JR, He L and Lemasters JJ: Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader. Anal Biochem 295: 220-226, 2001.
10. Custodio JBA, Cardoso CMP and Almeida LM: Thiol protecting agents and antioxidants inhibit the mitochondrial permeability transition promoted by etoposide: implications in the prevention of etoposide-induced apoptosis. Chem Biol Interact 140: 169-184, 2002.
11. Gottlieb E, Armour SM, Harris MH and Thompson CB: Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10: 709-717, 2003.
12. Zamzami N, Maisse C, Metivier D and Kroemer G: Measurement of membrane permeability and permeability transition of mitochondria. Methods Cell Biol 65: 147-158, 2001.
13. Halestrap AP: The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta 973: 355-382, 1989.
14. Henry TR, Solem LE and Wallace KB: Channel-specific induction of the cyclosporine A-sensitive mitochondrial permeability transition by menadione. J Toxicol Environ Health 45: 489-504, 1995.
15. Bernardi P: Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79: 1127-1155, 1999.
16. Zoratti M and Szabo I: The mitochondrial permeability transition. Biochim Biophys Acta 1241: 139-176, 1995.
17. Ly JD, Grubb DR and Lawen A: The mitochondrial membrane potential (ΔΨm) in apoptosis; an update. Apoptosis 8: 115-128, 2003.
18. Bernardi P, Broekemeier KM and Pfeiffer DR: Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr 26: 509-517, 1994.
19. Pervaiz S, Seyed MA, Hirpara JL, Clément M-V and Loh KW: Purified photoproducts of merocyanine 540 trigger cytochrome c release and caspase 8-dependent apoptosis in human leukemia and melanoma cells. Blood 93: 4096-4108, 1999.
20. Gunter KK and Gunter TE: Transport of calcium by mitochondria. J Bioenerg Biomembr 26: 471-485, 1994.
21. Bernardi P and Petronilli V: The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr 28: 131-138, 1996.
22. Decaudin D, Marzo I, Brenner C and Kroemer G: Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy (Review). Int J Oncol 12: 141-152, 1998.
23. Grad JM, Cepero E and Boise LH: Mitochondria as targets for established and novel anti-cancer agents. Drug Resist Updates 4: 85-91, 2001.
24. Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R and Zhivotovsky B: Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene 21: 65-77, 2002.
25. Hockenbery DM: A mitochondrial Achilles' heel in cancer? Cancer Cell 2: 1-2, 2002.
26. Solary E, Bettaieb A, Dubrez-Daloz L and Corcos L: Mitochondria as a target for inducing death of malignant hematopoietic cells. Leuk Lymphoma 44: 563-574, 2003.
27. Morisaki T and Katano M: Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer. Curr Med Chem 10: 2517-2521, 2003.
28. Dias N and Bailly C: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70: 1-12, 2005.
29. Robertson JD, Gogvadze V, Zhivotovsky B and Orrenius S: Distinct pathways for stimulation of cytochrome c release. J Biol Chem 275: 32438-32443, 2000.
30. Huigsloot M, Tijdens IB, Mulder GJ and van de Water B: Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 277: 35869-35879, 2002.
31. Rebbaa A, Chou PM, Emran M and Mirkin BL: Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria. Cancer Chemother Pharmacol 48: 423-428, 2001.
32. Tong X, Lin S, Fujii M and Hou D-X: Echinocystic acid induces apoptosis in HL-60 cells through mitochondria-mediated death pathway. Cancer Lett 212: 21-32, 2004.
33. Zhang S, Ong C-N and Shen H-M: Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis. Cancer Lett 211: 175-188, 2004.
34. Kim JS, Lee JM, Chwae Y-J, et al: Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways. Biochem Pharmacol 67: 1459-1468, 2004.
35. Ahn HJ, Kim YS, Kim J-U, Han SM, Shin JW and Yang HO: Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem 91: 1043-1052, 2004.
36. Shibata M-A, Ito Y, Morimoto J and Otsuki Y: Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis 25: 1887-1898, 2004.
37. Hsu M-J, Chao Y, Chang Y-H, et al: Cell apoptosis induced by a synthetic carbazole compound LCY-2-CHO is mediated through activation of caspase and mitochondrial pathways. Biochem Pharmacol 70: 102-112, 2005.
38. Ko CH, Shen S-C, Hsu C-S and Chen Y-C: Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspases. Biochem Pharmacol 69: 913-927, 2005.
39. Sen N, Das BB, Ganguly A, et al: Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ 11: 924-936, 2004.
40. Piret J-P, Arnould T, Fuks B, Chatelain P, Remacle J and Michiels C: Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells. Biochem Pharmacol 67: 611-620, 2004.
41. Schempp CM, Kirkin V, Simon-Haarhaus B, et al: Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 21: 1242-1250, 2002.
42. Marchetti P, Zamzami N, Joseph B, et al: The novel retinoid 6- [3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res 59: 6257-6266, 1999.
43. Ricci J-E, Waterhouse N and Green DR: Mitochondrial functions during cell death, a complex (I-V) dilemma. Cell Death Differ 10: 488-492, 2003.
44. Brdiczka D, Beutner G, Rück A, Dolder M and Wallimann T: The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition. BioFactors 8: 235-242, 1998.
45. Donovan M and Cotter TG: Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 1644: 133-147, 2004.
46. Shimizu S, Narita M and Tsujimoto Y: Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487, 1999.
47. Zamzami N and Kroemer G: The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2: 67-71, 2001.
48. Marzo I, Brenner C, Zamzami N, et al: Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027-2031, 1998.
49. Wei MC, Zong WX, Cheng EH, et al: Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
50. Gogvadze V, Robertson JD, Enoksson M, Zhivotovsky B and Orrenius S: Mitochondrial cytochrome c release may occur by volume-dependent mechanisms not involving permeability transition. Biochem J 378: 213-217, 2004.
51. Vyssokikh M, Zorova L, Zorov D, Heimlich G, Jürgensmeier J, Schreiner D and Brdiczka D: The intramitochondrial cytochrome c distribution varies correlated to the formation of a complex between VDAC and the adenine nucleotide translocase: this affects Bax-dependent cytochrome c release. Biochim Biophys Acta 1644: 27-36, 2004.
52. Kim TH, Zhao Y, Barber MJ, Kuharsky DK and Yin XM: Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 275: 39474-39481, 2000.
53. Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y and Tsujimoto Y: Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 152: 237-250, 2001.
54. Bossy-Wetzel E, Newmeyer DD and Green DR: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17: 37-49, 1998.
55. Zhuang J, Dinsdale D and Cohen GM: Apoptosis, in human monocytic THP.1 cells, results in the release of cytochrome c from mitochondria prior to their ultracondensation, formation of outer membrane discontinuities and reduction in inner membrane potential. Cell Death Differ 5: 953-962, 1998.
56. Hearps AC, Burrows J, Connor CE, Woods GM, Lowenthal RM and Ragg SJ: Mitochondrial cytochrome c release precedes transmembrane depolarization and caspase-3 activation during ceramide-induced apoptosis of Jurkat T cells. Apoptosis 7: 387-394, 2002.
57. Scorrano L and Korsmeyer SJ: Mechanisms of cytochrome c release by proapoptotic Bcl-2 family members. Biochem Biophys Res Commun 304: 437-444, 2003.
58. 2+- independent mechanisms that are regulated by Bax. J Biol Chem 276: 19066-19071, 2001.
59. Machida K, Hayashi Y and Osada H: A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release by a mitochondrial permeability transition-independent mechanism. J Biol Chem 277: 31243-31248, 2002.
60. Bauer MK, Schubert A, Rocks O and Grimm S: Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 147: 1493-1502, 1999.
61. Halestrap A: A pore way to die. Nature 434: 578-579, 2005.
62. Zoratti M, Szabò I and De Marchi U: Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 1706: 40-52, 2005.
63. Walter L, Miyoshi H, Leverve X, Bernardi P and Fontaine E: Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report. Free Radic Res 36: 405-412, 2002.
64. Henry TR and Wallace KB: Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol Appl Pharmacol 134: 195-203, 1995.
65. Fontaine E, Ichas F and Bernardi P: A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 273: 25734-25740, 1998.
66. Kristián T, Gertsch J, Bates TE and Siesjö BK: Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: effect of cyclosporin A and ubiquinone 0. J Neurochem 74: 1999-2009, 2000.
67. Ichas F and Mazat JP: From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta 1366: 33-50, 1998.